Home/Filings/4/A/0001209191-23-039505
4/A//SEC Filing

Ho William Tai-Wei 4/A

Accession 0001209191-23-039505

CIK 0001740279other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 6:25 PM ET

Size

6.0 KB

Accession

0001209191-23-039505

Insider Transaction Report

Form 4/AAmended
Period: 2023-04-14
Ho William Tai-Wei
DirectorPRESIDENT AND CEO10% Owner
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-04-14+393,950393,950 total
    Exercise: $1.21Exp: 2033-04-14Common Stock (393,950 underlying)
Footnotes (2)
  • [F1]The initial Form 4 inadvertently listed the wrong exercise price and expiration date. This amendment reflects the revised exercise price and expiration date for this option.
  • [F2]Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

IN8BIO, INC.

CIK 0001740279

Entity typeother

Related Parties

1
  • filerCIK 0001830914

Filing Metadata

Form type
4/A
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:25 PM ET
Size
6.0 KB